• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Celladon

edit

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. The company was founded in 2000 and is based in La Jolla, California.

Milestones

edit

• 
  Celladon received $21.8M in Series C funding. (11/09)
  Posted 11/2/09 at 6:45pm
• 
  Celladon added Krisztina M. Zsebo as CEO.
  Posted 11/2/09 at 6:45pm
• 
  Celladon added Roger Hajjar as Co-Founder and Scientific Advisor.
  Posted 11/2/09 at 6:45pm

Videos

Screenshots

edit

Sources

1. Celladon, Inc.: Series C $21.8M (onbiovc.com) [edit]